Normal view MARC view ISBD view

Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves. [Review]

MedStar author(s):

Citation: Jacc: Cardiovascular Interventions. 15(18):1777-1793, 2022 Sep 26.PMID: 36137681Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Aortic Valve Stenosis | *Bioprosthesis | *Heart Valve Prosthesis | *Heart Valve Prosthesis Implantation | *Transcatheter Aortic Valve Replacement | Aortic Valve Stenosis/dg [Diagnostic Imaging] | Aortic Valve Stenosis/et [Etiology] | Aortic Valve Stenosis/su [Surgery] | Aortic Valve/dg [Diagnostic Imaging] | Aortic Valve/su [Surgery] | Heart Valve Prosthesis Implantation/ae [Adverse Effects] | Heart Valve Prosthesis Implantation/mt [Methods] | Humans | Prosthesis Design | Prosthesis Failure | Transcatheter Aortic Valve Replacement/ae [Adverse Effects] | Transcatheter Aortic Valve Replacement/mt [Methods] | Treatment OutcomeYear: 2022 ISSN:

1936-8798

Name of journal: JACC. Cardiovascular interventionsAbstract: Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves. Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.All authors: Bapat VN, De Backer O, Fabris T, Khan JM, Landes U, Latib A, Nai Fovino L, Rogers T, Sathananthan J, Sondergaard L, Tang GHL, Tarantini G, Van Mieghem NM, Waksman R, Zaid SFiscal year: FY2023 Digital Object Identifier:

https://dx.doi.org/10.1016/j.jcin.2022.07.035

Date added to catalog: 2022-10-20

Holdings ( 1 )
Title notes ( 2 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	36137681	Available		36137681

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves. Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

English